Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by 99942Apophis


V.TLT

RE:RE:RE:The number to beat is 39%CR...(for now).

That 40B would be for the perfect dream of NMIBC,  MIBC, vaccine, ...

January 7, 2024

V.TLT

RE:The number to beat is 39%CR...(for now).

wildbird1 wrote: We all know that the Big Pharma that will strike a deal with...

January 7, 2024

V.TLT

RE:RE:RE:Coming soon in a news release ( I hope ) this month ?

N0taP00p wrote: Given how the uptake for Pfizer and Moderna vaccines has...

January 6, 2024

V.TLT

Appointments to note

The hiring of Dr. Kaouthar Lbiati and Matthew Perraton being moved to the IR...

January 5, 2024

V.TLT

RE:RE:RE:The money situation

Infinity wrote: I am yet to come across FDA Using the Term Pre-BTD.  It...

January 4, 2024

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Email from Matthew Perraton

pssst  pssst  Benedictus,  cover yourself up man, everyone can...

January 4, 2024

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Email from Matthew Perraton

Lesalpes29 wrote: Lot of noise around a letter to subscribers! Is it illegal,...

January 3, 2024

V.TLT

RE:RE:RE:RE:Email from Matthew Perraton

Interesting person, Matthew Perraton is a wealth financial planner and as...

January 3, 2024

V.TLT

RE:RE:RE:RE:RE:RE:RE:Email from Matthew Perraton

Thanks  johannn

January 2, 2024

V.TLT

RE:RE:RE:RE:RE:Email from Matthew Perraton

IO12009 wrote: I got the email and it is the answer to many questions that...

January 2, 2024

V.TLT

RE:RE:Email from Matthew Perraton

Matthew Perraton is and has been a director of Theralase for many years. ...

January 2, 2024

V.TLT

RE:RE:RE:Looking fwd to exciting Quarter Finally :-)

StevenBirch wrote: The usual negative players say BTD won't move the...

January 2, 2024

V.PTU

RE:Re: Share dilution

winr88 wrote: Purepoint has been exploring for Uranium for nearly 20 years...

December 31, 2023

V.TLT

RE:RE:RE:The pre-BTD

Oilminerdeluxe wrote: Thanks, man. I appreciate it. Turning into a nervous...

December 28, 2023

V.TLT

RE:The pre-BTD

Oilminerdeluxe wrote: Say, that pre-BTD thing that is supposed to be sent in...

December 28, 2023

V.AZS

RE:Excellent article that puts AZS at the head of the class.

Good read, thanks winr88,  have a happy Xmas to everyone here.

December 24, 2023

V.TLT

RE:bid and ask (manipulation? who knows)

DJDawg wrote: I'm not one for saying that stock price movements are...

December 19, 2023

V.TLT

RE:RE:I know a sale when i see one :-) Keep the faith

Drug repositioning, also referred to as drug repurposing or drug reprofiling,...

December 16, 2023

V.TLT

RE:share price

Its not tax loss selling, nor panic or disappointment, it is blatant share...

December 15, 2023

V.TLT

RE:CG0070 + Pembrolizumab...Not even close to TLT-Ruvidar.

Thanks for your usual excellent research wildbird1 

December 14, 2023

Featured Company